PofoliaShared via Pofolia

Current Opinion in Hematology· 2016Q1

Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31)

Panida Lertkiatmongkol, Danying Liao, Heng Mei, Yu Hu et al.

Short summary

Platelet/endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as an adhesive stress-response protein at endothelial cell junctions, maintaining barrier integrity and accelerating restoration of vascular permeability after disruption.

AI-generated from the title and abstract; the full text is not read.

Key points

  • PECAM-1 (CD31) is highly expressed at endothelial cell-cell junctions.
  • It functions as an adhesive stress-response protein, maintaining junctional integrity.
  • PECAM-1 accelerates the restoration of the vascular permeability barrier after disruption.
  • Antibodies targeting PECAM-1's extracellular domain can modulate its adhesion properties.

AI-generated from the title and abstract; the full text is not read.

Abstract

PURPOSE OF REVIEW: The purpose of this article is to describe the function of the vascular cell adhesion and signaling molecule, platelet/endothelial cell adhesion molecule-1 (PECAM-1), in endothelial cells, with special emphasis on its role in maintaining and restoring the vascular permeability barrier following disruption of the endothelial cell junction. RECENT FINDINGS: In addition to its role as an inhibitory receptor in circulating platelets and leukocytes, PECAM-1 is highly expressed at endothelial cell-cell junctions, where it functions as an adhesive stress-response protein to both maintain endothelial cell junctional integrity and speed restoration of the vascular permeability barrier following inflammatory or thrombotic challenge. SUMMARY: Owing to the unique ability of antibodies that bind the membrane proximal region of the extracellular domain to trigger conformational changes leading to affinity modulation and homophilic adhesion strengthening, PECAM-1 might be an attractive target for treating vascular permeability disorders.

The authors' abstract, as published at the source. Current Opinion in Hematology, 2016 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Immunology and Allergy

Immunology and AllergyMedicine